COAG Insider Trading Activity and SEC Form 4 Filings
COAG insider trading summary
Over the past 12 months, insiders at Hemab Therapeutics Holdings, Inc. (COAG) reported 76 open-market purchases worth $326.3M by 6 insiders and no sales on SEC Form 4. Net insider buying was $326.3M.
Latest COAG insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Peter Kolchinsky | 10% Owner | Buy | $1.5M (61,523 @ $24.98) |
| Jun 16, 2026 | Ra Capital Management, L.P. | Insider | Buy | $1.5M (61,523 @ $24.98) |
| Jun 16, 2026 | Rajeev M. Shah | 10% Owner | Buy | $1.5M (61,523 @ $24.98) |
| Jun 16, 2026 | RA Capital Healthcare Fund LP | 10% Owner | Buy | $1.5M (61,523 @ $24.98) |
| Jun 15, 2026 | Ra Capital Management, L.P. | Insider | Buy | $153K (6,146 @ $24.89) |
| Jun 15, 2026 | Rajeev M. Shah | 10% Owner | Buy | $153K (6,146 @ $24.89) |
| Jun 15, 2026 | RA Capital Healthcare Fund LP | 10% Owner | Buy | $153K (6,146 @ $24.89) |
| Jun 15, 2026 | Peter Kolchinsky | 10% Owner | Buy | $153K (6,146 @ $24.89) |
| May 20, 2026 | Ra Capital Management, L.P. | Insider | Buy | $25K (996 @ $24.94) |
| May 20, 2026 | RA Capital Healthcare Fund LP | 10% Owner | Buy | $25K (996 @ $24.94) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.